ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI
Hôpital Fribourgeois
10 participants
Jan 7, 2026
INTERVENTIONAL
Conditions
Summary
This study aims to understand how the volumes and speeds of intravenous injection of a recent type of contrast agent can be optimized in order to improve the information provided by medical images. To do this, five MRI scans lasting approximately 30 minutes will be performed on 10 healthy volunteers over a period of approximately 10 months. The images will then be analyzed by three radiologists who will view the images in different orders, without knowing which injection parameters were used. They will decide, based on their impressions but also on precise measurements in the images, which parameters produce the best images.
Eligibility
Inclusion Criteria5
- Adults ≥18 and ≤ 40 years of age at time of Informed Consent
- Informed Consent as documented by signature
- No known chronic conditions (defined by ICD-10 codes)
- Non-smoking
- French speaking
Exclusion Criteria10
- Women who are pregnant or breast feeding,
- Intention to become pregnant during the course of the study,
- Contraindications to the class of drug (gadopiclenol and gadoteric acid) under study, e.g. known hypersensitivity or allergy
- Claustrophobia and contraindication for MRI according to institutional practices
- Prior MRI examination with contrast agent and washout period of ≤ 2 weeks
- Prior liver, spleen, pancreatic or bowel surgery
- Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.)
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Participation in another study with investigational medicinal product within the 30 days preceding and during the present study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Each participant undergoes five abdominal MRI exams with distinct injection protocols in a random order with at least a 2-week interval between each exams.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07346131